IL-34-mediated fibroblast-like synoviocyte-macrophage crosstalk drives bone erosion in rheumatoid arthritis through RANKL-dependent osteoclastogenesis

• by Xin Li, Yurou Yang, Shuao Zhang, Yujing Cai, Aiqi Wang, Na Xu

• June 17, 2026

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

• by Andrea Surnit

• June 12, 2026

• 5 min

Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives

• by Wen, Jianting , Liu, Jian

• June 8, 2026

Hair Repigmentation Reported With Baricitinib in Canities Subita

A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.

• by Andrea Surnit

• June 15, 2026

• 4 min